v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from operating activities:    
Net income (loss) $ 8,127,313 $ (3,753,268)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation expense 1,781
Amortization expense 96,614
Common stock issued for services 5,561,500
Changes in operating assets and liabilities:    
Accounts receivable (11,983,046) (3,019,965)
Deferred revenue (150,000)
Accounts payable and payroll liabilities 3,406,175 215,934
Accrued expenses – related party 34,992
Accounts payable – related party (68,209)
Accrued interest 55,351 13,250
Accounts payable settled with common stock 156,000
Original issuance discount, net (153,140) (60,001)
Deferred financial costs, net (35,000)
Net Cash used in operating activities (448,960) (1,104,759)
Cash flow from investing activities:    
Fixed asset, net (10,202) (6,498)
Net Cash Provided by Investing Activities (10,202) (6,498)
Net Cash provided by financing activities:    
Notes payable 585,330 400,000
Note settlement 315,104
Net Cash Provided by financing activities 585,330 715,104
Net change in Cash and cash equivalents for the year 126,168 (396,153)
Cash and cash equivalents at the beginning of the year 76,356 472,509
Cash and cash equivalents at the end of the year 202,524 76,356
Non-cash investing and financing activities:    
Common stock issued for note settlement 315,104
Common stock issued for payable $ 156,000